CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 35 filers reported holding CELLECTIS S A in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,844 | -17.1% | 121,420 | +3.2% | 0.00% | -20.0% |
| Q2 2023 | $231,553 | +3.3% | 117,689 | +1.3% | 0.01% | 0.0% |
| Q1 2023 | $224,195 | +42.2% | 116,163 | +54.8% | 0.01% | +25.0% |
| Q4 2022 | $157,609 | -25.3% | 75,052 | -18.4% | 0.00% | -20.0% |
| Q3 2022 | $211,000 | -1.4% | 91,963 | +21.6% | 0.01% | 0.0% |
| Q2 2022 | $214,000 | -36.9% | 75,633 | +1.3% | 0.01% | -16.7% |
| Q1 2022 | $339,000 | -56.3% | 74,654 | +171.5% | 0.01% | -70.0% |
| Q3 2018 | $776,000 | -8.2% | 27,499 | -7.9% | 0.02% | -13.0% |
| Q2 2018 | $845,000 | +231.4% | 29,862 | +181.6% | 0.02% | +228.6% |
| Q3 2016 | $255,000 | -20.8% | 10,604 | -12.4% | 0.01% | -30.0% |
| Q2 2016 | $322,000 | -5.0% | 12,101 | -1.9% | 0.01% | 0.0% |
| Q1 2016 | $339,000 | -20.8% | 12,335 | -10.6% | 0.01% | -23.1% |
| Q4 2015 | $428,000 | +27.8% | 13,797 | +8.5% | 0.01% | +30.0% |
| Q3 2015 | $335,000 | +65.0% | 12,717 | +125.6% | 0.01% | +66.7% |
| Q2 2015 | $203,000 | – | 5,636 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |